IllnessMonosomy 7 predisposition syndromes, differential diagnosis
Summary
Short information
Comprehensive differential diagnostic panel for Monosomy 7 predisposition syndromes, differential diagnosis comprising 43 or altogether 77 curated genes according to the clinical signs
ID
MP9923
Number of genes
66
Accredited laboratory test
Examined sequence length
107,5 kb (Core-/Core-canditate-Genes)
152,4 kb (Extended panel: incl. additional genes)
152,4 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
- EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications
NGS +
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
BLM | 4254 | NM_000057.4 | AR | |
BRCA2 | 10257 | NM_000059.4 | AR | |
BRIP1 | 3750 | NM_032043.3 | AR | |
CBL | 2721 | NM_005188.4 | AD | |
CEBPA | 1077 | NM_004364.5 | AD | |
DDX41 | 1935 | NM_016222.4 | AD | |
DNAJC21 | 2049 | NM_001012339.3 | AR | |
EFL1 | 3382 | NM_001040610.3 | AR | |
ELANE | 804 | NM_001972.4 | AD | |
ERCC6L2 | 2106 | NM_001010895.4 | AR | |
FANCA | 4368 | NM_000135.4 | AR | |
FANCB | 2580 | NM_001018113.3 | XL, Sus | |
FANCC | 1677 | NM_000136.3 | AR | |
FANCE | 1611 | NM_021922.3 | AR, Sus | |
FANCF | 1125 | NM_022725.4 | AR, Sus | |
FANCG | 1869 | NM_004629.2 | AR, Sus | |
FANCI | 3987 | NM_001113378.2 | AR, Sus | |
G6PC3 | 1041 | NM_138387.4 | AR | |
GATA1 | 1242 | NM_002049.4 | XLR | |
GATA2 | 1443 | NM_032638.5 | AD, Sus | |
GFI1 | 1269 | NM_005263.5 | AD | |
HAX1 | 840 | NM_006118.4 | AR | |
JAGN1 | 552 | NM_032492.4 | AR | |
KRAS | 567 | NM_004985.5 | AD | |
LIG4 | 2736 | NM_002312.3 | AR | |
MLH1 | 2271 | NM_000249.4 | AD, AR, Sus | |
MSH2 | 2805 | NM_000251.3 | n.k. | |
MSH6 | 4083 | NM_000179.3 | n.k. | |
NF1 | 8457 | NM_001042492.3 | AD | |
NRAS | 570 | NM_002524.5 | AD, Sus | |
PMS2 | 2589 | NM_000535.7 | AR, Sus | |
PTPN11 | 1782 | NM_002834.5 | AD | |
RUNX1 | 1443 | NM_001754.5 | AD, Gen Fusion | |
SAMD9 | 4770 | NM_001193307.2 | AD | |
SAMD9L | 4756 | NM_152703.5 | AD | |
SBDS | 753 | NM_016038.4 | AR | |
SRP54 | 1534 | NM_001146282.2 | AD | |
TCIRG1 | 2493 | NM_006019.4 | AR | |
TP53 | 1182 | NM_000546.6 | AD | |
VPS45 | 1617 | NM_007259.5 | AR | |
WRN | 4299 | NM_000553.6 | AR | |
XPC | 2823 | NM_004628.5 | AR | |
ACD | 1647 | NM_001082486.2 | AD, AR | |
ANKRD26 | 5133 | NM_014915.3 | AD | |
ATM | 9171 | NM_000051.4 | AR | |
CTC1 | 3654 | NM_025099.6 | AR | |
DKC1 | 1545 | NM_001363.5 | XLR | |
ETV6 | 1359 | NM_001987.5 | Gen Fusion | |
MPL | 1908 | NM_005373.3 | AD, AR, SMu | |
NBN | 2265 | NM_002485.5 | AR, Sus | |
NHP2 | 273 | NM_001034833.2 | AR | |
NOP10 | 195 | NM_018648.4 | AR | |
PARN | 1920 | NM_002582.4 | AR, AD | |
RPL11 | 537 | NM_000975.5 | AD | |
RPL35A | 333 | NM_000996.4 | AD | |
RPL5 | 894 | NM_000969.5 | AD | |
RPS10 | 498 | NM_001014.5 | AD | |
RPS17 | 408 | NM_001021.6 | AD | |
RPS19 | 438 | NM_001022.4 | AD | |
RPS24 | 393 | NM_033022.4 | AD | |
RPS26 | 348 | NM_001029.5 | AD | |
RTEL1 | 3732 | NM_032957.5 | AD, AR | |
SRP72 | 1833 | NM_001267722.2 | AD | |
TERT | 3399 | NM_198253.3 | Sus | |
TINF2 | 1356 | NM_001099274.3 | AD | |
WRAP53 | 1647 | NM_001143990.2 | AR |
Informations about the disease
Synonyms
- Alias: Watson disease (NF1)
- Allelic: Colorectal cancer (TP53)
- Allelic: Dursun syndrome (G6PC3)
- Allelic: Leukemia, juvenile myelomonocytic (NF1)
- Allelic: Noonan syndrome 3 (KRAS)
- Allelic: Oculoectodermal syndrome, somatic (KRAS)
- Allelic: Tumoral calcinosis, familial, normophosphatemic (SAMD9)
- Anemia, XL, with/-out neutropenia and/or platelet abnormalities (GATA1)
- Aplastic anemia, susceptibility to (SBDS)
- Ataxia-pancytopenia syndrome (SAMD9L)
- Ataxia-telangiectasia (ATM) Bloom syndrome (BLM)
- Bone marrow failure syndrome 1 (SRP72)
- Bone marrow failure syndrome 2 (ERCC6L2)
- Bone marrow failure syndrome 3 (DNAJC21)
- Bone marrow failure syndrome 5 (TP53)
- Cardiofaciocutaneous syndrome 2 (KRAS)
- Cerebroretinal microangiopathy with calcifications + cysts (CTC1)
- Colorectal cancer, hereditary nonpolyposis, type 1 (MSH2)
- Colorectal cancer, hereditary nonpolyposis, type 2 (MLH1)
- Colorectal cancer, hereditary nonpolyposis, type 4 (PMS2)
- Colorectal cancer, hereditary nonpolyposis, type 5 (MSH6)
- Diamond-Blackfan anemia 1 (RPS19)
- Diamond-Blackfan anemia 10 (RPS26)
- Diamond-Blackfan anemia 3 (RPS24)
- Diamond-Blackfan anemia 4 (RPS17)
- Diamond-Blackfan anemia 5 (RPL35A)
- Diamond-Blackfan anemia 6 (RPL5)
- Diamond-Blackfan anemia 7 (RPL11)
- Diamond-Blackfan anemia 9 (RPS10)
- Dyskeratosis congenita, AD 2 (TERT)
- Dyskeratosis congenita, AD 3 (TINF2)
- Dyskeratosis congenita, AD 4 (RTEL1)
- Dyskeratosis congenita, AR 1 (NOP10)
- Dyskeratosis congenita, AR 2 (NHP2)
- Dyskeratosis congenita, AR 3 (WRAP53)
- Dyskeratosis congenita, AR 4 (TERT)
- Dyskeratosis congenita, AR 5 (RTEL1)
- Dyskeratosis congenita, AR 6 (PARN)
- Dyskeratosis congenita, XL (DKC1)
- Emberger syndrome (GATA2)
- Familial adenomatous polyposis 4 (MSH3)
- Fanconi anemia, complementation group A (FANCA)
- Fanconi anemia, complementation group B (FANCB)
- Fanconi anemia, complementation group C (FANCC)
- Fanconi anemia, complementation group D1 (BRCA2)
- Fanconi anemia, complementation group D2 (FANCD2)
- Fanconi anemia, complementation group E (FANCE)
- Fanconi anemia, complementation group F (FANCF)
- Fanconi anemia, complementation group G (FANCG)
- Fanconi anemia, complementation group I (FANCI)
- Fanconi anemia, complementation group J (BRIP1)
- Immunodeficiency 21 (GATA2)
- Juvenile myelomonocytic leukemia (CBL)
- LEOPARD syndrome 1 (PTPN11)
- LIG4 syndrome (LIG4)
- Leukemia, acute myeloid (CEBPA)
- Leukemia, acute myeloid (RUNX1)
- Leukemia, acute myeloid (TERT)
- Leukemia, acute myeloid, somatic (CEBPA)
- Leukemia, acute myeloid, somatic (ETV6)
- Leukemia, acute myeloid, somatic (KRAS)
- Leukemia, acute myeloid, susceptibility to (GATA2)
- Leukemia, juvenile myelomonocytic, somatic (PTPN11)
- Leukemia, megakaryoblastic, with/-out Down syndrome, somatic (GATA1)
- MIRAGE syndrome (SAMD9)
- Monosomy 7 myelodysplasia + leukemia syndrome 1 (SAMD9L)
- Monosomy 7 myelodysplasia and leukemia syndrome 2 (SAMD9)
- Multiple myeloma, resistance to (LIG4)
- Myelodysplastic syndrome, susceptibility to (GATA2)
- Myelofibrosis with myeloid metaplasia, somatic (MPL)
- Myeloproliferative/lymphoproliferative neoplasms, familial, multiple types, susceptibility (DDX41)
- Neurofibromatosis, familial spinal (NF1)
- Neurofibromatosis, type 1 (NF1)
- Neurofibromatosis-Noonan syndrome (NF1)
- Neutropenia, cyclic (ELANE)
- Neutropenia, nonimmune chronic idiopathic, of adults (GFI1)
- Neutropenia, severe congenital 1, AD (ELANE)
- Neutropenia, severe congenital 2, AD (GFI1)
- Neutropenia, severe congenital 3, AR (HAX1)
- Neutropenia, severe congenital 4, AR (G6PC3)
- Neutropenia, severe congenital, 5, AR (VPS45)
- Neutropenia, severe congenital, 6, AR (JAGN1)
- Neutropenia, severe congenital, 8, AD (SRP54)
- Nijmegen breakage syndrome (NBN)
- Noonan syndrome 1 (PTPN11)
- Noonan syndrome 6 (NRAS)
- Noonan syndrome-like disorder with/-out juvenile myelomonocytic leukemia (CBL)
- Osteopetrosis, AR 1 (TCIRG)
- Platelet disorder, familial, with associated myeloid malignancy (RUNX1)
- Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1 (TERT)
- Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3 (RTEL1)
- Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4 (PARN)
- RAS-associated autoimmune leukoproliferative disorder (KRAS)
- RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic (NRAS)
- Revesz syndrome (TINF2)
- Shwachman-Diamond syndrome (SBDS)
- Shwachman-Diamond syndrome 2 (EFL1)
- Thrombocythemia 2 (MPL)
- Thrombocytopenia 2 (ANKRD26)
- Thrombocytopenia 5 (ETV6)
- Thrombocytopenia with beta-thalassemia, XL (GATA1)
- Thrombocytopenia, XL, with/-out dyserythropoietic anemia (GATA1)
- Thrombocytopenia, congenital amegakaryocytic (MPL)
- Werner syndrome (WRN)
- Xeroderma pigmentosum, group C (XPC)
Heredity, heredity patterns etc.
- AD
- AR
- Gen Fusion
- SMu
- Sus
- XL
- XLR
- n.k.
OMIM-Ps
- Multiple OMIM-Ps
ICD10 Code
Bioinformatics and clinical interpretation
No text defined